{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:03:58Z","timestamp":1790363038298,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FIPE\/HCPA"},{"name":"Shire"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.clinbiochem.2014.02.014","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T03:01:21Z","timestamp":1393297281000},"page":"657-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fabry disease: A new approach for the screening of females in high-risk groups"],"prefix":"10.1016","volume":"47","author":[{"given":"Gabriela","family":"Pasqualim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Sperb-Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Graef","family":"Burin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiane","family":"Michelin-Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Matte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0005","series-title":"Metab. Mol. basis Inherit. Dis","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0010","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/nar\/17.8.3301","article-title":"Nucleotide sequence of the human alpha-galactosidase A gene","volume":"17","author":"Kornreich","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380030204","article-title":"Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.clinbiochem.2014.02.014_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"International Collaborative Fabry Disease Study Group. Safety and efficacy of recombinant human alpha-galactosidase A \u2013 replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0040","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1590\/S0100-879X2006005000138","article-title":"Genomic analysis of Brazilian patients with Fabry disease","volume":"40","author":"Pereira","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0055","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.clinbiochem.2011.03.141","article-title":"Whole-blood alpha-d-galactosidase A activity for the identification of Fabry's patients","volume":"44","author":"Massaccesi","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2350-11-19","article-title":"Frequency of Fabry disease in male and female haemodialysis patients in Spain","volume":"11","author":"Gaspar","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","article-title":"Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers","volume":"353","author":"Linthorst","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cca.2009.02.008","article-title":"Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper","volume":"403","author":"Olivova","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0075","series-title":"Fabry disease","author":"Gal","year":"2010"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10545-010-9261-9","article-title":"Toward a consensus in the laboratory diagnostics of Fabry disease \u2014 recommendations of a European expert group","volume":"34","author":"Gal","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.clinbiochem.2014.02.014_bb0085","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.ijcard.2012.06.069","article-title":"Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy","volume":"167","author":"Terryn","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-0004.2011.01689.x","article-title":"Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene","volume":"81","author":"Ferri","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.20144","article-title":"Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography","volume":"25","author":"Shabbeer","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0100","first-page":"491","article-title":"The neurological complications of Anderson\u2013Fabry disease (alpha-galactosidase A deficiency) \u2014 investigation of symptomatic and presymptomatic patients","volume":"75","author":"Morgan","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0105","first-page":"157","article-title":"Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<420::AID-AJMG6>3.0.CO;2-Z","article-title":"Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG)","volume":"84","author":"Ashton-Prolla","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/3.4.667","article-title":"Detection of 8 new mutations in the \u03b1-galactosidase A gene in Fabry disease","volume":"3","author":"Davies","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","article-title":"Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype","volume":"76","author":"Shabbeer","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/jhg.2012.32","article-title":"New mutations in the GLA gene in Brazilian families with Fabry disease","volume":"57","author":"Tura\u00e7a","year":"2012","journal-title":"J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes","volume":"3","author":"Eng","year":"1997","journal-title":"Mol Med"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/hmg\/2.7.1051","article-title":"Mutation analysis in patients with the typical form of Anderson\u2013Fabry disease","volume":"2","author":"Davies","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s100380170088","article-title":"Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype","volume":"46","author":"Ashley","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"Shabbeer","year":"2006","journal-title":"Hum Genomics"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/3.3.503","article-title":"Six novel mutations in the alpha-galactosidase A gene in families with Fabry disease","volume":"3","author":"van Amstel JK","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0165","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI114027","article-title":"Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene","volume":"83","author":"Bernstein","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0170","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.cca.2012.07.011","article-title":"First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene","volume":"413","author":"Paciotti","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0175","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cca.2010.03.009","article-title":"Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry","volume":"411","author":"Dajnoki","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2014.02.014_bb0180","series-title":"Fabry Dis. Perspect. from 5 Years FOS","article-title":"Biochemical and genetic diagnosis of Fabry disease","author":"Winchester","year":"2006"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:43:26Z","timestamp":1757864606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":35,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0009912014000757"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.014","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabry disease: A new approach for the screening of females in high-risk groups","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}